Company Overview: Nephros

About the Company

Nephros
Facebook Tweeter Linkedin Google Plus

Nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. Nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins.

Nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance:

• Filtration – as low as 5 nanometers

• Flow rate – minimal disruption

• Filter life – up to 12 months

Nephros was founded in 1997, by healthcare professionals affiliated with Columbia University Medical Center, initially to address the needs of chronic renal failure patients.


Investor Toolkit

Company News

  • Nephros Announces Preliminary Financial Results for Fourth Quarter 2017

    Anticipates Over 80% Year-over-Year Product Revenue Growth for the Quarter SOUTH ORANGE, NJ, Jan. 04, 2018 (GLOBE NEWSWIRE) — Nephros, Inc. (NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an...

  • Nephros Receives $1.8 Million in Cash from Sale of Tax Credits

    SOUTH ORANGE, NJ, Dec. 13, 2017 (GLOBE NEWSWIRE) — Nephros, Inc. (NEPH) a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis (HD)...

  • Nephros Reports Third Quarter 2017 Financial Results

    RIVER EDGE, NJ–(Marketwired – Nov 9, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis...

  • Nephros Provides Corporate Update and Announces Preliminary Third Quarter 2017 Revenue

    RIVER EDGE, NJ–(Marketwired – Oct 16, 2017) – Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for use with a hemodialysis...

Email Subscription

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address